Retracted: Naringenin Inhibits Cell Migration, Invasion, and Tumor Growth by Regulating circFOXM1/miR-3619-5p/SPAG5 Axis in Lung Cancer
Authors:
- 1 December 2020
- journal article
- retracted article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 35 (10) , e826-e838
Abstract
Background: Naringenin has been reported to play an anticancer role by inhibiting the metastasis of tumor cells, but the roles of naringenin and the molecular mechanisms mediated by it in lung cancer remain to be elucidated. Materials and Methods: Cell migration and invasion were determined by transwell assay. The expression levels of circular RNA FOXM1 (circFOXM1), microRNA-3619-5p (miR-3619-5p), and sperm-associated antigen 5 (SPAG5) in lung cancer were measured by quantitative real-time polymerase chain reaction. Western blot assay was used to detect the levels of all proteins. The interaction between microRNA and circular RNA or mRNA was validated using dual-luciferase reporter assay. The models of xenograft mice were established to evaluate the effect of naringenin on tumor growth in vivo. Results: Naringenin restrained migration and invasion of lung cancer cells in a dose-dependent manner. In addition, naringenin could decrease the expression levels of circFOXM1 and SPAG5, which were highly expressed in lung cancer and increase the level of miR-3619-5p with low expression in lung cancer in a dose-dependent manner. miR-3619-5p has an interactive relationship with circFOXM1 or SPAG5, and circFOXM1 could enhance SPAG5 expression by sponging miR-3619-5p in naringenin-treated lung cancer cells. Moreover, naringenin inhibited cell migration, invasion, and tumor growth by regulating circFOXM1/miR-3619-5p/SPAG5 axis in lung cancer. Conclusion: Naringenin hindered cell metastasis in vitro and tumor growth in vivo by reducing circFOXM1 and SPAG5 expression and inducing the expression of miR-3619-5p in lung cancer.Keywords
This publication has 34 references indexed in Scilit:
- Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and −9Experimental and Therapeutic Medicine, 2016
- Role of MiR-3619-5p in β-Catenin-Mediated Non-Small Cell Lung Cancer Growth and InvasionCellular Physiology and Biochemistry, 2015
- Naringenin Inhibits UVB Irradiation-Induced Inflammation and Oxidative Stress in the Skin of Hairless MiceJournal of Natural Products, 2015
- Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathyNeurological Research, 2015
- Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP-2Molecular Medicine Reports, 2014
- SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathwayCell Death & Disease, 2014
- Naringenin Decreases Invasiveness and Metastasis by Inhibiting TGF-β-Induced Epithelial to Mesenchymal Transition in Pancreatic Cancer CellsPLOS ONE, 2012
- Lung Adenocarcinoma: Lessons in Translation from Bench to BedsideMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Epithelial-Mesenchymal TransitionsCell, 2004